{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:26:48Z","timestamp":1790627208571,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic hepatitis C virus (HCV) infection is a curable disease, but the absence of a vaccine remains a major problem in infection prevention. The lack of small animal models and limited access to human liver tissue impede the study of hepatic antiviral immunity and the development of new vaccine strategies. We recently developed an immune-competent mouse model using an HCV-related rodent hepacivirus which shares immunological features with human viral hepatitis. In this study, we used this new model to investigate the role of invariant natural killer T (iNKT) cells during hepacivirus infection <jats:italic>in vivo.<\/jats:italic> These cells are enriched in the liver, however their role in viral hepatitis is not well defined. Using high-dimensional flow cytometry and NKT cell deficient mice we analyzed a potential role of iNKT cells in mediating viral clearance, liver pathology or immune-regulation during hepacivirus infection. In addition, we identified new immune-dominant MHC class I restricted viral epitopes and analyzed the impact of iNKT cells on virus-specific CD8+ T cells. We found that rodent hepacivirus infection induced the activation of iNKT cell subsets with a mixed NKT1\/NKT2 signature and significant production of type 2 cytokines (IL-4 and IL-13) during acute infection. While iNKT cells were dispensable for viral clearance, the lack of these cells caused higher levels of liver injury during infection. In addition, the absence of iNKT cells resulted in increased effector functions of hepatic antiviral T cells. In conclusion, our study reports a regulatory role of hepatic iNKT cells during hepacivirus infection <jats:italic>in vivo<\/jats:italic>. Specifically, our data suggest that iNKT cells skewed towards type 2 immunity limit liver injury during acute infection by mechanisms that include the regulation of effector functions of virus-specific T cells.<\/jats:p>","DOI":"10.3389\/fimmu.2022.953151","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T18:09:08Z","timestamp":1662746948000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatic iNKT cells produce type 2 cytokines and restrain antiviral T cells during acute hepacivirus infection"],"prefix":"10.3389","volume":"13","author":[{"given":"Svjetlana","family":"Raus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrett","family":"Lopez-Scarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Luthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Billerbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.semcancer.2014.01.004","article-title":"Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma","volume":"26","author":"Shlomai","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2018.06.002","article-title":"Hepatitis b and c","volume":"22","author":"Mysore","year":"2018","journal-title":"Clin Liver Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-a, non-b hepatitis to hepatitis c virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis c vaccine development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba2351","article-title":"Immune surveillance of the liver by T cells","volume":"5","author":"Ficht","year":"2020","journal-title":"Sci Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/v13091871","article-title":"Towards a systems immunology approach to understanding correlates of protective immunity against hcv","volume":"13","author":"Shoukry","year":"2021","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in hcv infections","volume":"61","author":"Heim","year":"2014","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.08.011","article-title":"T Cell responses during hbv and hcv infections: Similar but not quite the same","volume":"51","author":"Shoukry","year":"2021","journal-title":"Curr Opin Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0034-2","article-title":"Tissue-specific functions of invariant natural killer T cells","volume":"18","author":"Crosby","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01582","article-title":"The roles of liver-resident lymphocytes in liver diseases","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"eabf0095","DOI":"10.1126\/science.abf0095","article-title":"Early-life imprinting of unconventional T cells and tissue homeostasis","volume":"374","author":"Constantinides","year":"2021","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21378.1","article-title":"Recent advances in inkt cell development","volume":"9","author":"Hogquist","year":"2020","journal-title":"F1000Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01858","article-title":"Natural killer T cells: An ecological evolutionary developmental biology perspective","volume":"8","author":"Kumar","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200141","article-title":"Genomic and transcriptional mechanisms governing innate-like T lymphocyte development","volume":"209","author":"Morgan","year":"2022","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.048","article-title":"Hallmarks of tissue-resident lymphocytes","volume":"164","author":"Fan","year":"2016","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2811","article-title":"Hepatitis b virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity","volume":"18","author":"Zeissig","year":"2012","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02424","article-title":"The role of Cd1d and Mr1 restricted T cells in the liver","volume":"9","author":"Huang","year":"2018","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22715","article-title":"Cd56+ T cells inhibit hepatitis c virus replication in human hepatocytes","volume":"49","author":"Ye","year":"2009","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155432","article-title":"Peripheral blood inkt cell activation correlates with liver damage during acute hepatitis c","volume":"7","author":"Senff","year":"2022","journal-title":"JCI Insight"},{"key":"B22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2017.09.016","article-title":"Inkt cells orchestrate a switch from inflammation to resolution of sterile liver injury","volume":"47","author":"Liew","year":"2017","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100334","article-title":"Invariant nkt cells promote the development of highly cytotoxic multipotent Cxcr3(+)Ccr4(+)Cd8(+) T cells that mediate rapid hepatocyte allograft rejection","volume":"207","author":"Zimmerer","year":"2021","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754106","article-title":"Activation of inkt cells facilitates liver repair after hepatic ischemia reperfusion injury through acceleration of macrophage polarization","volume":"12","author":"Goto","year":"2021","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/s41467-022-30759-w","article-title":"Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity","volume":"13","author":"Umeshappa","year":"2022","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036970","article-title":"Animal models of hepatitis c virus infection","volume":"10","author":"Ploss","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01933-14","article-title":"Detection of zoonotic pathogens and characterization of novel viruses carried by commensal rattus norvegicus in new York city","volume":"5","author":"Firth","year":"2014","journal-title":"MBio"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal1962","article-title":"Mouse models of acute and chronic hepacivirus infection","volume":"357","author":"Billerbeck","year":"2017","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001255","article-title":"Development and function of invariant natural killer T cells producing T(H)2- and T(H)17-cytokines","volume":"10","author":"Watarai","year":"2012","journal-title":"PLoS Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.12.017","article-title":"Nkt cell-plasmacytoid dendritic cell cooperation Via Ox40 controls viral infection in a tissue-specific manner","volume":"30","author":"Diana","year":"2009","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0301-x","article-title":"Heterogeneity in the initiation, development and function of type 2 immunity","volume":"20","author":"Gause","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010887","article-title":"Invariant natural killer T-cell subsets have diverse graft-Versus-Host-Disease-Preventing and antitumor effects","volume":"138","author":"Maas-Bauer","year":"2021","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003272","article-title":"Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine gvhd","volume":"5","author":"Hirai","year":"2021","journal-title":"Blood Adv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-752444","article-title":"Invariant natural killer T cells ameliorate murine chronic gvhd by expanding donor regulatory T cells","volume":"129","author":"Du","year":"2017","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer Via nkt cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41423-020-00561-z","article-title":"Innate lymphocytes: Pathogenesis and therapeutic targets of liver diseases and cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800614","article-title":"Differential activation of hepatic invariant nkt cell subsets plays a key role in progression of nonalcoholic steatohepatitis","volume":"201","author":"Maricic","year":"2018","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.012","article-title":"Deconstructing inkt cell development at single-cell resolution","volume":"43","author":"Baranek","year":"2022","journal-title":"Trends Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat6280","article-title":"Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury","volume":"363","author":"Harrison","year":"2019","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323771","article-title":"The human liver microenvironment shapes the homing and function of Cd4(+) T-cell populations","volume":"71","author":"Wiggins","year":"2022","journal-title":"Gut"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.953151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T18:09:13Z","timestamp":1662746953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.953151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2022.953151"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.953151","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"article-number":"953151"}}